Committee for the Protection of Human Subjects

The Committee for the Protection of Human Subjects (CPHS) serves as the University of Oregon's Institutional Review Board (IRB). An IRB is an independent committee required under federal regulations to review and approve or disapprove, as well as monitor, research involving human participants. The mission of the CPHS/IRB is to protect the rights and welfare of par in University of Oregon research.

Submissions eligible for the Exempt or Expedited review process are reviewed on an ongoing basis throughout the year.

IRB Meeting Dates for Full Board Review

Note: The meeting dates below only apply to submissions requiring review by the fully convened IRB.
Meeting Date - Fall 2023

September 6, 2023

September 20, 2023

October 4, 2023

October 18, 2023

November 1, 2023

November 15, 2023

December 6, 2023

December 20, 2023

Meeting Date - Winter 2024

January 3, 2024

January 17, 2024

February 7, 2024

February 21, 2024

March 6, 2024

March 20, 2024

Meeting Date - Spring 2024

April 3, 2024

April 17, 2024

May 1, 2024

May 15, 2024

June 5, 2024

June 19, 2024

Meeting Date - Summer 2024

July 3, 2024

July 17, 2024

August 7, 2024

August 21, 2024

Meetings start at 8:30a.m. and are held remotely for the time being due to COVID-19. When in person meeting resume they are held at 677 East 12th Ave, Suite 500 in the main conference room (Mt. Hood - Room 506). 

Studies may be submitted at any time. Once a study is determined to require full board review and is ready for consideration by the fully convened IRB, the study is assigned to the next available committee meeting agenda.  

NOTE: Meetings will be canceled if there are no study submissions.

Committee Meeting Attendance

Frequently, the committee will request a representative of the research team attend the meeting in order to explain and/or clarify portions of the proposed research. In such instances, a Research Compliance Services (RCS) staff member will contact the investigator with the anticipated time the study will be considered.

The investigator in attendance should have their IRB materials accessible so they can answer questions that the board may ask. In some circumstances, they may also be asked to provide a brief 2-3 minute overview of the proposed research focusing on the procedures involving human subjects, the risks, and the measures in place to mitigate the risks. The floor will then be opened up to members of the board to ask any immediate questions. Afterwards, the investigator will be excused for the final deliberation and vote. An RCS Staff member will contact the investigator within three business days to convey the meeting outcome.


If you have questions, please contact Research Compliance Services.